A Phase 1/3 Clinical Trial to Evaluate the Safety and Efficacy of HUTOX Compared to Botox® in Subjects With Moderate to Severe Crow's Feet Lines
A Phase 1/3 Clinical Trial to Evaluate the Safety and Efficacy of HUTOX Compared to Botox® in Subjects With Moderate to Severe Crow's Feet Lines
A Phase 1/3 Clinical Trial to Evaluate the Safety and Efficacy of HUTOX Compared to Botox® in
 Subjects With Moderate to Severe Crow's Feet Lines
Inclusion Criteria:

 -  Bilaterally symmetrical moderate-to-severe CFL at maximum smile on the FWS as rated by
 the investigator

 Exclusion Criteria:

 -  Volunteer who has history of any diseases following. (myasthenia gravis, Eaton-Lambert
 syndrome, amyotrophic lateral sclerosis etc.)

 -  From screening, Subject who get a plastic Surgery within 48 Weeks

 -  Subject who has skin disorder including infection and scar on injection site

 -  Subject who takes a medication including skeletal muscle relaxants, Aminoglycoside,
 lincomycin, anticholinergic drug, benzodiazepine, benzamide etc.

 -  Subject who takes a medication including anticoagulant, antithrombotic drug except low
 dose aspirin (below 325 mg/day)

 -  Any condition that, in the view of the investigator, would interfere with study
 participation